Idraparinux
Idraparinux[edit | edit source]
Idraparinux is a long-acting anticoagulant that belongs to the class of synthetic pentasaccharides. It is designed to inhibit Factor Xa, an important enzyme in the coagulation cascade. Idraparinux is used in the prevention and treatment of thromboembolic disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE).
Mechanism of Action[edit | edit source]
Idraparinux works by selectively inhibiting Factor Xa, which is a crucial component in the conversion of prothrombin to thrombin. By inhibiting Factor Xa, idraparinux effectively reduces the formation of fibrin, thereby preventing the development of blood clots. Unlike heparin, idraparinux does not require antithrombin as a cofactor for its activity.
Pharmacokinetics[edit | edit source]
Idraparinux is administered via subcutaneous injection and has a long half-life, allowing for once-weekly dosing. It is highly bioavailable and does not require renal adjustment in patients with renal impairment. The drug is not metabolized by the liver, and its elimination is primarily through the kidneys.
Clinical Use[edit | edit source]
Idraparinux is primarily used for the prevention of venous thromboembolism (VTE) in patients undergoing major orthopedic surgery, such as hip replacement or knee replacement. It is also used in the long-term treatment of atrial fibrillation to prevent stroke and systemic embolism.
Side Effects[edit | edit source]
The most common side effect of idraparinux is bleeding, which can range from minor bruising to severe hemorrhage. Other potential side effects include thrombocytopenia, allergic reactions, and injection site reactions.
Advantages and Disadvantages[edit | edit source]
One of the main advantages of idraparinux is its long half-life, which allows for less frequent dosing compared to other anticoagulants like warfarin or low molecular weight heparins. However, this long half-life can also be a disadvantage in cases of overdose or bleeding complications, as the effects of the drug cannot be rapidly reversed.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
